Hochman David P 4
4 · Orchestra BioMed Holdings, Inc. · Filed Mar 27, 2026
Research Summary
AI-generated summary of this filing
Orchestra BioMed (OBIO) CEO & Chair David P. Hochman Withholds 32,438 Shares
What Happened
David P. Hochman, Chief Executive Officer, Chairperson and a director of Orchestra BioMed (OBIO), had 32,438 shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units (RSUs). The withholding was recorded at $4.57 per share, totaling $148,242. This was a tax-withholding/net settlement of RSUs — not an open-market sale.
Key Details
- Transaction date: 2026-03-25
- Filing date: 2026-03-27 (timely)
- Action/code: F — payment of tax liability via share withholding (no market sale)
- Shares withheld/disposed: 32,438 at $4.57 per share; total value $148,242
- Footnote: Issuer withheld shares to satisfy tax obligations on RSU vesting; no shares were sold in the market (F1).
- Shares owned after transaction: Not specified in the provided filing.
Context
This was a routine withholding of shares to cover taxes on vested RSUs (a net share settlement), which is common and does not necessarily signal the insider’s view of the stock. Because no shares were sold on the open market, this transaction is less informative about insider sentiment than a cash sale or purchase.
Insider Transaction Report
- Tax Payment
Common Stock, par value $0.0001 per share ("Common Stock")
[F1]2026-03-25$4.57/sh−32,438$148,242→ 1,054,029 total
- 439,482(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 3,140(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.